| Primary |
| Pain |
37.4% |
| Drug Use For Unknown Indication |
13.2% |
| Back Pain |
11.0% |
| Cancer Pain |
4.1% |
| Fibromyalgia |
4.1% |
| Bipolar Disorder |
2.7% |
| Convulsion |
2.7% |
| Neck Pain |
2.7% |
| Neuropathy Peripheral |
2.7% |
| Pancreatic Carcinoma Metastatic |
2.3% |
| Product Used For Unknown Indication |
2.3% |
| Prophylaxis Of Nausea And Vomiting |
2.3% |
| Anaesthesia |
1.8% |
| Anxiety |
1.8% |
| Nutritional Support |
1.8% |
| Accidental Exposure |
1.4% |
| Blood Pressure |
1.4% |
| Gastroenteritis Eosinophilic |
1.4% |
| Headache |
1.4% |
| Insomnia |
1.4% |
|
| Vomiting |
10.0% |
| Pain |
8.6% |
| Unresponsive To Stimuli |
8.6% |
| Product Quality Issue |
7.1% |
| Somnolence |
7.1% |
| Withdrawal Syndrome |
7.1% |
| Overdose |
5.7% |
| Urinary Tract Infection |
5.7% |
| Weight Decreased |
5.7% |
| Drug Level Increased |
4.3% |
| Nausea |
4.3% |
| Anaphylactic Reaction |
2.9% |
| Anaphylactic Shock |
2.9% |
| Drug Withdrawal Syndrome |
2.9% |
| Dyspnoea |
2.9% |
| Hyperhidrosis |
2.9% |
| Oedema Peripheral |
2.9% |
| Serotonin Syndrome |
2.9% |
| Speech Disorder |
2.9% |
| Swelling |
2.9% |
|
| Secondary |
| Pain |
16.7% |
| Drug Use For Unknown Indication |
15.9% |
| Back Pain |
7.0% |
| Product Used For Unknown Indication |
7.0% |
| Anaesthesia |
5.9% |
| Cancer Pain |
5.9% |
| Induction Of Anaesthesia |
5.4% |
| Maintenance Of Anaesthesia |
4.3% |
| Gastroenteritis Eosinophilic |
4.0% |
| Intentional Overdose |
3.2% |
| Nutritional Support |
3.2% |
| Suicide Attempt |
3.2% |
| Bronchoscopy |
2.7% |
| Hypertension |
2.7% |
| Pneumonia Aspiration |
2.4% |
| Breakthrough Pain |
2.2% |
| Fibromyalgia |
2.2% |
| Hypotonia |
2.2% |
| Multiple Myeloma |
2.2% |
| Analgesia |
1.9% |
|
| Vomiting |
14.8% |
| Respiratory Arrest |
7.4% |
| Tachycardia |
7.4% |
| Gastroenteritis Eosinophilic |
6.2% |
| Pain |
6.2% |
| Unresponsive To Stimuli |
6.2% |
| Bradycardia |
4.9% |
| Somnolence |
4.9% |
| Wrong Technique In Drug Usage Process |
4.9% |
| Accidental Overdose |
3.7% |
| Nausea |
3.7% |
| Pneumonia Aspiration |
3.7% |
| Poisoning |
3.7% |
| Rash |
3.7% |
| Serotonin Syndrome |
3.7% |
| Ventricular Tachycardia |
3.7% |
| Withdrawal Syndrome |
3.7% |
| Anxiety |
2.5% |
| Burning Sensation |
2.5% |
| Peak Expiratory Flow Rate Decreased |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
55.8% |
| Pain |
6.8% |
| Product Used For Unknown Indication |
3.0% |
| Anaesthesia |
2.8% |
| Hypertension |
2.8% |
| Back Pain |
2.5% |
| Diffuse Large B-cell Lymphoma |
2.5% |
| Constipation |
2.3% |
| Depression |
2.3% |
| Breast Cancer |
2.1% |
| Non-small Cell Lung Cancer |
2.1% |
| Premedication |
2.0% |
| Multiple Myeloma |
1.8% |
| Prophylaxis |
1.8% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Maintenance Of Anaesthesia |
1.7% |
| Nausea |
1.7% |
| Crohn's Disease |
1.5% |
| Acute Lymphocytic Leukaemia |
1.4% |
| Rheumatoid Arthritis |
1.4% |
|
| Vomiting |
15.9% |
| Respiratory Failure |
8.5% |
| Drug Ineffective |
7.3% |
| Unresponsive To Stimuli |
7.3% |
| Vascular Resistance Systemic Decreased |
7.3% |
| Renal Failure Acute |
6.1% |
| Somnolence |
4.9% |
| Cholecystitis |
3.7% |
| Death |
3.7% |
| Drug Level Increased |
3.7% |
| Hypotension |
3.7% |
| Pneumothorax |
3.7% |
| Rhabdomyolysis |
3.7% |
| Sepsis |
3.7% |
| Tremor |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Dyspnoea |
2.4% |
| Generalised Oedema |
2.4% |
| Medication Error |
2.4% |
| Oedema Peripheral |
2.4% |
|
